243 related articles for article (PubMed ID: 15361556)
1. 2004 Dr. Gary J. Becker Young Investigator Award: Relative thermosensitivity of cytotoxic drugs used in transcatheter arterial chemoembolization.
Ahrar K; Newman RA; Pang J; Vijjeswarapu MK; Wallace MJ; Wright KC
J Vasc Interv Radiol; 2004 Sep; 15(9):901-5. PubMed ID: 15361556
[TBL] [Abstract][Full Text] [Related]
2. Transcatheter arterial chemoembolization (TACE) in treatment of hepatocellular carcinoma.
Barone M; Ettorre GC; Ladisa R; Schiavariello M; Santoro C; Francioso G; Vinciguerra V; Francavilla A
Hepatogastroenterology; 2003; 50(49):183-7. PubMed ID: 12630019
[TBL] [Abstract][Full Text] [Related]
3. The effect of doxorubicin on the changes of serum vascular endothelial growth factor (VEGF) in patients with hepatocellular carcinoma after transcatheter arterial chemoembolization (TACE).
Leelawat K; Laisupasin P; Kiatdilokrut A; Pongtongpool T; Narong S; Samkhumphim N; Ket-Horm S
J Med Assoc Thai; 2008 Oct; 91(10):1539-43. PubMed ID: 18972897
[TBL] [Abstract][Full Text] [Related]
4. Interferons modify in vitro proliferation of human bladder transitional cell carcinoma in the presence of doxorubicin and mitomycin C.
Okamoto E; Kinne RK; Sökeland J
J Urol; 1996 Oct; 156(4):1492-5. PubMed ID: 8808915
[TBL] [Abstract][Full Text] [Related]
5. The difference in chemosensitivity to antineoplastic agents of human hepatocellular carcinoma cells under normo-oxygenated or hypoxic conditions.
Yamagata M; Kanematsu T; Matsumata T; Utsunomiya T; Ikeda Y; Sugimachi K
Eur J Surg Oncol; 1992 Aug; 18(4):379-82. PubMed ID: 1325926
[TBL] [Abstract][Full Text] [Related]
6. MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization.
Lewandowski RJ; Tepper J; Wang D; Ibrahim S; Miller FH; Kulik L; Mulcahy M; Ryu RK; Sato K; Larson AC; Salem R; Omary RA
J Vasc Interv Radiol; 2008 May; 19(5):698-705. PubMed ID: 18440458
[TBL] [Abstract][Full Text] [Related]
7. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
Lu W; Li YH; He XF; Zhao JB; Chen Y; Mei QL
Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240
[TBL] [Abstract][Full Text] [Related]
8. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD
J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739
[TBL] [Abstract][Full Text] [Related]
9. Screening of anticancer drugs for chemoembolization of hepatocellular carcinoma.
Boulin M; Guiu S; Chauffert B; Aho S; Cercueil JP; Ghiringhelli F; Krause D; Fagnoni P; Hillon P; Bedenne L; Guiu B
Anticancer Drugs; 2011 Sep; 22(8):741-8. PubMed ID: 21487286
[TBL] [Abstract][Full Text] [Related]
10. RF ablation with adjuvant therapy: comparison of external beam radiation and liposomal doxorubicin on ablation efficacy in an animal tumor model.
Solazzo S; Mertyna P; Peddi H; Ahmed M; Horkan C; Goldberg SN
Int J Hyperthermia; 2008 Nov; 24(7):560-7. PubMed ID: 18608584
[TBL] [Abstract][Full Text] [Related]
11. Hypothermic modulation of doxorubicin, cisplatin and radiation cytotoxicity in vitro.
Lundgren-Eriksson L; Hultborn R; Henriksson R
Anticancer Res; 2001; 21(5):3275-80. PubMed ID: 11848483
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of curcumin, alone or in combination with cisplatin or doxorubicin, on human hepatic cancer cells. Analysis of their possible relationship to changes in NF-kB activation levels and in IAP gene expression.
Notarbartolo M; Poma P; Perri D; Dusonchet L; Cervello M; D'Alessandro N
Cancer Lett; 2005 Jun; 224(1):53-65. PubMed ID: 15911101
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
Lu W; Li YH; Yu ZJ; He XF; Chen Y; Zhao JB; Zhu ZY
Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284
[TBL] [Abstract][Full Text] [Related]
14. Optimal strategies for combining transcatheter arterial chemoembolization and radiofrequency ablation in rabbit VX2 hepatic tumors.
Mostafa EM; Ganguli S; Faintuch S; Mertyna P; Goldberg SN
J Vasc Interv Radiol; 2008 Dec; 19(12):1740-8. PubMed ID: 18951042
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency thermal ablation sharply increases intratumoral liposomal doxorubicin accumulation and tumor coagulation.
Ahmed M; Monsky WE; Girnun G; Lukyanov A; D'Ippolito G; Kruskal JB; Stuart KE; Torchilin VP; Goldberg SN
Cancer Res; 2003 Oct; 63(19):6327-33. PubMed ID: 14559820
[TBL] [Abstract][Full Text] [Related]
16. Pilot study of combination therapy with transcatheter arterial infusion chemotherapy using iodized oil and percutaneous radiofrequency ablation during occlusion of hepatic blood flow for hepatocellular carcinoma.
Shiraishi R; Yamasaki T; Saeki I; Okita K; Yamaguchi Y; Uchida K; Terai S; Sakaida I
Am J Clin Oncol; 2008 Aug; 31(4):311-6. PubMed ID: 18845987
[TBL] [Abstract][Full Text] [Related]
17. Effect of heating on lethality due to hyperthermia and selected chemotherapeutic drugs.
Herman TS; Sweets CC; White DM; Gerner EW
J Natl Cancer Inst; 1982 Mar; 68(3):487-91. PubMed ID: 6950177
[TBL] [Abstract][Full Text] [Related]
18. Arrhenius relationships from the molecule and cell to the clinic.
Dewey WC
Int J Hyperthermia; 2009 Feb; 25(1):3-20. PubMed ID: 19219695
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and toxicity of transcatheter arterial chemoembolization with Cisplatin suspended in lipiodol for unresectable hepatocellular carcinoma].
Uyama N; Hatano E; Maetani Y; Isoda H; Shibata T; Taura K; Oe S; Naito M; Yasuchika K; Fujii H; Ikai I; Uemoto S
Gan To Kagaku Ryoho; 2008 May; 35(5):775-80. PubMed ID: 18487912
[TBL] [Abstract][Full Text] [Related]
20. [Transcatheter hepatic arterial chemoembolization on recurrent hepatocellular carcinoma after resection].
Ge NL; Ren ZG; Ye SL; Lin ZY; Xia JL; Gan YH; Li LX; Shen YF; Tang ZY
Zhonghua Zhong Liu Za Zhi; 2005 Jun; 27(6):380-2. PubMed ID: 16117905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]